Aa Aa Aa
  • Investor Information Overview

Corporate Profile
Sucampo Pharmaceuticals, Inc. is a global biopharmaceutical company focused on innovative research, discovery, development and commercialization of proprietary drugs based on prostones and other novel drug technologies. The therapeutic potential of prostones was first discovered by our cofounder, Dr. Ryuji Ueno, and  More >>
Stock Quote
SCMP (Common Stock)
ExchangeNASDAQ GM (US Dollar)
Change (%) Stock is Up 0.12 (1.78%)
Data as of 04/22/14 4:00 p.m. ET
Refresh quote
Recent NewsRSS   | More >>
03/25/14Sucampo Co-Founder and Chairman Emeritus, Dr. Ryuji Ueno, to Receive Visionary Award From the Foundation Fighting BlindnessPrinter Friendly Version
03/14/14Sucampo and Takeda Announce Update on Liquid Formulation Program for AMITIZA(R) (lubiprostone)Printer Friendly Version
03/12/14Sucampo Receives Notice that Second Indication for AMITIZA for Opioid-Induced Constipation Is Not Approved by Medicines and Healthcare Products Regulatory Agency in U.K.Printer Friendly Version
03/05/14Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2014 ROTH ConferencePrinter Friendly Version
Upcoming Events
There are currently no events scheduled.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.